The present invention discloses novel macrocyclic compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such macrocycles as well as methods of using them to treat disorders associated with the HCV protease.
本发明披露了新型大环化合物,具有HCV
蛋白酶抑制活性,以及制备这种化合物的方法。在另一实施例中,本发明披露了包含这种大环化合物的药物组合物,以及使用它们治疗与HCV
蛋白酶相关的疾病的方法。